THE EFFICACY AND SAFETY

Clinical trials for THE EFFICACY AND SAFETY explained in plain language.

Never miss a new study

Get alerted when new THE EFFICACY AND SAFETY trials appear

Sign up with your email to follow new studies for THE EFFICACY AND SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New triple-drug attack targets hard-to-treat lymphoma

Disease control Not yet recruiting

This early-stage study tests whether combining three drugs (sonrotoclax, zanubrutinib, and obinutuzumab) can shrink or eliminate mantle cell lymphoma in people with aggressive forms of the disease. About 28 newly diagnosed patients with high-risk features will receive the combina…

Matched conditions: THE EFFICACY AND SAFETY

Phase: PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated Apr 26, 2026 20:02 UTC

THE EFFICACY AND SAFETY

Get alerted when new THE EFFICACY AND SAFETY trials appear

New triple-drug attack targets hard-to-treat lymphoma